Approval · Notice of Compliance 20113 · 2017
TICLOPIDINE: Notice of Compliance 20113
Issued December 1, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20113
- Date
- December 1, 2017
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Transfer of DIN ownership Revisions to the product monograph and labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TICLOPIDINE | 02237701 | Dormant |
Medicinal ingredients
- TICLOPIDINE HCL 250 MG per TAB